Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03230903 · ClinicalTrials.gov registry record · NA

Physical Telerehabilitation in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT03230903: Completed NA study of Multiple Sclerosis, sponsored by Columbia University.

NCT03230903 is a NA study of Multiple Sclerosis that has completed, run by Columbia University. The registered enrollment target is 78 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03230903, a NA study of Multiple Sclerosis, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The study aims to evaluate the efficacy of the MS HAT (Multiple Sclerosis Home Automated Telemanagement) System as an adjunct to the current standard of medical care for patients with MS (PwMS). The individual patient with MS will be the unit of analysis. For each participant, the investigators will assess the effect of Home Automated Telemanagement (HAT) on functional outcomes, levels of disablement including impairment, activity and participation, socio-behavioral parameters, and satisfaction with medical care as described below.

Primary Outcome

Cardiorespiratory fitness will be measured by oxygen consumption

Conditions Studied

Interventions

  • OTHER Usual Care
  • OTHER Home telerehabilitation

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2016-10
Est. Completion 2020-09
Phase NA
Columbia University

958 total trials

What the finished NCT03230903 record still lists

NCT03230903 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT03230903 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT03230903 about?

NCT03230903 is a clinical study titled "Physical Telerehabilitation in Multiple Sclerosis". The study aims to evaluate the efficacy of the MS HAT (Multiple Sclerosis Home Automated Telemanagement) System as an adjunct to the current standard of medical care for patients with MS (PwMS). The individual patient with MS will be the unit of analysis. For each participant, the investigators will...

What is the current status of trial NCT03230903?

This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2016-10. Estimated completion is 2020-09.

What conditions does trial NCT03230903 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT03230903?

The interventions under investigation include: Usual Care (OTHER), Home telerehabilitation (OTHER).

Who is sponsoring clinical trial NCT03230903?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03230903 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03230903's enrollment target sits among peer trials

78 144th of 315 higher than 171 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02397668 · 78 participants · NA

    CorMatrix Cor TRICUSPID ECM Valve Replacement Study

  • NCT03321656 · 78 participants · Phase 2

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

  • NCT03687814 · 78 participants · NA

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

  • NCT04018872 · 78 participants · Phase 2

    Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03230903, the US trial registry maintained by the National Library of Medicine. NCT03230903 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.